NCT03157167 2025-03-05
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Navidea Biopharmaceuticals
Phase 1 Completed
Clinical Trials
4 trialsNCT04096716 2023-12-21
Mapping Draining Lymph Nodes in CNS Malignancies
Washington University School of Medicine
Phase 1 Terminated
NCT03029988 2020-09-10
An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Navidea Biopharmaceuticals
Phase 1 Terminated
NCT02589366 2018-10-15
Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
University of California, San Diego
Phase 1 Terminated